Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians

Physiological Genomics

Volumn 2000, Issue 3, 2000, Pages 39-44

  Hegele, Robert A ^a   Cao, Henian ^a   Harris, Stewart B ^b   Zinman, Bernard ^c   Hanley, Anthony J ^c   Anderson, Carol M ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c NONE

Author keywords

Association study; Complex disease; Metabolism; Obesity

Indexed keywords

LAMIN; LEPTIN; NUCLEAR PROTEIN;

ADULT; ALLELE; AMERICAN INDIAN; ARTICLE; ASIAN; BLOOD; BODY COMPOSITION; BODY CONSTITUTION; BODY MASS; CANADA; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; MALE; MULTIVARIATE ANALYSIS; OBESITY; PHENOTYPE; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BODY COMPOSITION; BODY CONSTITUTION; BODY MASS INDEX; CANADA; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; HUMANS; INDIANS, NORTH AMERICAN; LAMINS; LEPTIN; MALE; MULTIVARIATE ANALYSIS; NUCLEAR PROTEINS; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE; VARIATION (GENETICS);

EID: 0034729587     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.2000.3.1.39     Document Type: Article

References (32)

1. Bonne G, DiBarletta MR, Varnous S, Becane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea JA, Duboc D, Fardeau M, Toniolo D, and Schwartz K. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21: 285-288, 1999.
2. Bouchard C, Pérusse L, Leblanc C, Tremblay A, and Theriault G. Inheritance of the amount and distribution of human body fat. Int J Obes 12: 205-215, 1998.
3. Burn J and Baraitser M. Partial lipoatrophy with insulin resistant diabetes and hyperlipidemia (Dunnigan syndrome). J Med Genet 23: 128-130, 1986.
4. Cao H and Hegele RA. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 9: 109-112, 2000.
5. Comuzzie AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD, Stern MP, MacCluer JW, and Blangero J. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 15: 273-276, 1997.
6. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, and Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292-295, 1996.
7. Fatkin D, MacRae C, Sasaki T, Wolff MR, Porchu M, Frenneaux M, Atherton J, Vidallet Jr HJ, Spudchi S, de Girolami U, Seidman JG, and Seidman CE. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction system disease. N Engl J Med 341: 1715-1724, 1999.
8. Flier J. Pushing the envelope on lipodystrophy. Nat Genet 24: 103-104, 2000.
9. Garg A, Peshock RM, and Fleckenstein JL. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab 84: 170-174, 1999.
10. Hager J, Dina C, Francke S, Dubois S, Houari M, Vatin V, Vaillant E, Lorentz N, Basdevant A, Clement K, Guy-Grand B, and Froguel P. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet 20: 304-308, 1998.
11. Hanley AJ, Harris SB, Gao XJ, Kwan J, and Zinman B. Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM. Diabetes Care 20: 1408-1415, 1997.
12. Harris SB, Gittelsohn J, Hanley AJG, Barnie A, Wolever TMS, Gao J, Logan A, and Zinman B. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 20:185-197, 1997.
13. Hegele RA, Harris SB, Hanley AJ, Sadikian S, Connelly PW, and Zinman B. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab 81: 4334-4337, 1996.
14. Hegele RA. Candidate genes, small effects, and the prediction of atherosclerosis. Crit Rev Clin Lab Sci 34: 343-367, 1997.
15. Hegele RA, Breckenridge WC, Cox DW, Maguire GF, Little JA, and Connelly PW. Elevated low density lipoprotein triglyceride concentrations in subjects heterozygous for hepatic lipase S267F variant. Arterioscler Thromb Vasc Biol 18: 1212-1216, 1998.
16. Hegele RA. The envelope, please: nuclear lamins and disease. Nat Med 6: 136-137, 2000.
17. Hegele RA, Hanley AJG, Zinman B, Harris SB, and Anderson CM. Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree. J Hum Genet 45: 184-187, 2000.
18. Hileman SM, Pierroz DD, and Flier JS. Leptin, nutrition, and reproduction: timing is everything. J Clin Endocrinol Metab 85: 804-807, 2000.
19. Hixson JE, Almasy L, Cole S, Birnbaum S, Mitchell BD, Mahaney MC, Stern MP, MacCluer JW, Blangero J, and Comuzzie AG. Normal variation in leptin levels in associated with polymorphisms in the proopiomelanocortin gene, POMC. J Clin Endocrinol Metab 84: 3187-3191, 1999.
20. Janssen JA, Koper JW, Stolk RP, Englaro P, Uitterlinden AG, Huang Q, van Leeuwen JP, Blum WF, Attanasio AM, Pols HA, Grobbee DE, de Jong FH, and Lamberts SW. Lack of associations between serum leptin, a polymorphism in the gene for the beta-3-adrenergic receptor and glucose tolerance in the Dutch population. Clin Endocrinol (Oxf) 49: 229-234, 1998.
21. Karvonen MK, Pesonen U, Heinonen P, Laakso M, Rissanen A, Naukkarinen H, Valve R, Uusitupa MI, and Koulu M. Identification of new sequence variants in the leptin gene. J Clin Endocrinol Metab 83: 3239-3242, 1998.
22. Kobberling J and Dunnigan MF. Familial partial lipodystrophy. J Med Genet 23: 120-127, 1986.
23. Lin F and Worman HJ. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem 268: 16321-16326, 1993.
24. Lonnqvist F, Arner P, Nordfors L, and Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1: 953-956, 1995.
25. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, Deeb S, Auwerx J, and Amouyel P. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet 7: 435-440, 1998.
26. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, and O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387: 903-908, 1997.
27. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057, 1979.
28. Oksanen L, Kaprio J, Mustajoki P, and Kontula K. A common pentanucleotide polymorphism of the 3′-untranslated part of the leptin receptor gene generates a putative stem-loop motif in the mRNA and is associated with serum insulin levels in obese individuals. Int J Obes Relat Metab Disord 22: 634-640, 1998.
29. SAS Institute. SAS/STAT Guide for Personal Computers (version 6). Cary, NC: SAS Institute, 1995.
30. Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, Singh BM, Schmidt H, Brabant G, Kumar S, Durrington PN, Gregory S, O'Rahilly S, and Trembath RC. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 24: 153-156, 2000.
31. Speckman RA, Garg A, Du F, Bennett L, Veile R, Arioglu E, Taylor SI, Lovett M, and Bowcock AM. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet 66: 1192-1198, 2000.
32. World Health Organization (WHO) Expert Committee on Diabetes Mellitus. Second report. In: Technical Report Series 646. Geneva: WHO, 1980.